(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TCF

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TCF

ST13

US500000079152345

Class

1, 5, 42

Filing

79152345

Registration

4903231

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

12/23/2025

Trademark type

Word

Nice classes

1, 5, 42

Filing date

06/13/2014

Registration date

02/23/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/22/2025

Last transaction

12/23/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

US

Examiner

ALTREE,NICHOLAS

Current location

Historical data usage

Holders and representatives

Holders

Kite Pharma, Inc.
Kite Pharma EU B.V.
D. B. (pessoa física)

Representatives

Cynthia Smuzynska GILEAD SCIENCES INC.,

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

chemical preparations for industrial and scientific usepolypeptides and proteins made by genetic engineeringincluding fusion proteins as well as nucleic acids encoding these polypeptides and proteinsbody cells and cells of the immune system of mammalsincluding human cells; analytical kits consisting of chemical reagents for industrial and scientific usefor the purificationdetection and immobilization of fusion proteinsfusion peptides and cellsbody cells and cells of the immune system of mammalsincluding human cells; diagnostic preparations except for medical purposes

Class 5

pharmaceutical and veterinary preparations for the treatment of cancerincluding hematologic cancersviral mediated diseasesbacterial mediated diseasesinflammatory and autoimmune diseasesincluding rheumatoid arthritisosteoarthritisCrohn's diseasepsoriasispsoriatic arthritispolypeptides and proteins made by genetic engineeringincluding fusion proteinscellsbody cells and cells of the immune system of mammalsincluding human cells ; diagnostic preparations for medical purposes

Class 42

Scientific and industrial research in the field of biochemistrydiagnostics and pharmaceutics; biochemical or pharmaceutical laboratory servicessynthesis of recombinant polypeptides and proteinscultivation and purification of cellsof body cells and cells of the immune system of mammals including human cells

Publications

History of USPTO decisions and trademark events.

57 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

12/22/2025

71AG

REGISTERED-SEC.71 ACCEPTED

12/22/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/02/2025

ES71

TEAS SECTION 71 RECEIVED

08/01/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

02/23/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

03/15/2024

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

09/11/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

07/23/2023

INPC

INVALIDATION PROCESSED

07/23/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

06/19/2023

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

10/19/2022

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

10/19/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/19/2022

CHLD

CHANGE OF OWNER RECEIVED FROM IB

02/18/2022

ES75

TEAS SECTION 71 & 15 RECEIVED

02/15/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/04/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/19/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/19/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/19/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/19/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/19/2021

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/23/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/15/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/25/2016

FIMP

FINAL DISPOSITION PROCESSED

05/25/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/23/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

02/23/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/08/2015

PUBO

PUBLISHED FOR OPPOSITION

12/08/2015

GPNX

NOTIFICATION PROCESSED BY IB

12/04/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/18/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/18/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/18/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/02/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/21/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/17/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/16/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/16/2015

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/30/2015

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/14/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/16/2015

GNRT

NON-FINAL ACTION E-MAILED

04/16/2015

CNRT

NON-FINAL ACTION WRITTEN

04/16/2015

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/09/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/09/2015

ALIE

ASSIGNED TO LIE

04/09/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/06/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/06/2015

RFNT

REFUSAL PROCESSED BY IB

10/24/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/08/2014

RFRR

REFUSAL PROCESSED BY MPU

10/08/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/08/2014

CNRT

NON-FINAL ACTION WRITTEN

10/07/2014

MAFR

APPLICATION FILING RECEIPT MAILED

10/04/2014

DOCK

ASSIGNED TO EXAMINER

09/30/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/30/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/25/2014

Continuous trademark protection

Get notified about every new filing that threatens TCF or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.